These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 12230093

  • 1. Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma.
    Sasaki M, Kuwabara Y, Koga H, Nakagawa M, Chen T, Kaneko K, Hayashi K, Nakamura K, Masuda K.
    Ann Nucl Med; 2002 Jul; 16(5):337-45. PubMed ID: 12230093
    [Abstract] [Full Text] [Related]

  • 2. 18F-FDG PET is superior to 67Ga SPECT in the staging of non-Hodgkin's lymphoma.
    Yamamoto F, Tsukamoto E, Nakada K, Takei T, Zhao S, Asaka M, Tamaki N.
    Ann Nucl Med; 2004 Sep; 18(6):519-26. PubMed ID: 15515753
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
    Kostakoglu L, Leonard JP, Kuji I, Coleman M, Vallabhajosula S, Goldsmith SJ.
    Cancer; 2002 Feb 15; 94(4):879-88. PubMed ID: 11920454
    [Abstract] [Full Text] [Related]

  • 8. Staging in childhood lymphoma: differences between FDG-PET and CT.
    Hermann S, Wormanns D, Pixberg M, Hunold A, Heindel W, Jürgens H, Schober O, Franzius C.
    Nuklearmedizin; 2005 Feb 15; 44(1):1-7. PubMed ID: 15711722
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma.
    Kotzerke J, Guhlmann A, Moog F, Frickhofen N, Reske SN.
    Eur J Nucl Med; 1999 Jan 15; 26(1):31-8. PubMed ID: 9933659
    [Abstract] [Full Text] [Related]

  • 11. Gallium-67 scintigraphy in lymphoma: is there a benefit of image fusion with computed tomography?
    Chajari M, Lacroix J, Peny AM, Chesnay E, Batalla A, Henry-Amar M, Delcambre C, Génot JY, Fruchard C, Bardet S.
    Eur J Nucl Med Mol Imaging; 2002 Mar 15; 29(3):380-7. PubMed ID: 12002715
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
    Moog F, Bangerter M, Diederichs CG, Guhlmann A, Kotzerke J, Merkle E, Kolokythas O, Herrmann F, Reske SN.
    Radiology; 1997 Jun 15; 203(3):795-800. PubMed ID: 9169707
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Imaging of malignant lymphomas with F-18 FDG coincidence detection positron emission tomography.
    Hwang K, Park CH, Kim HC, Kim H, Yoon S, Pai M, Kim S.
    Clin Nucl Med; 2000 Oct 15; 25(10):789-95. PubMed ID: 11043718
    [Abstract] [Full Text] [Related]

  • 18. Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma.
    Schöder H, Meta J, Yap C, Ariannejad M, Rao J, Phelps ME, Valk PE, Sayre J, Czernin J.
    J Nucl Med; 2001 Aug 15; 42(8):1139-43. PubMed ID: 11483671
    [Abstract] [Full Text] [Related]

  • 19. Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL).
    Najjar F, Hustinx R, Jerusalem G, Fillet G, Rigo P.
    Cancer Biother Radiopharm; 2001 Aug 15; 16(4):297-304. PubMed ID: 11603000
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.